Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Cash from Investing Activities (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Cash from Investing Activities for 10 consecutive years, with -$7.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 200.95% to -$7.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$43.6 million, a 231.48% decrease, with the full-year FY2025 number at -$43.6 million, down 231.48% from a year prior.
  • Cash from Investing Activities was -$7.3 million for Q4 2025 at Orthopediatrics, up from -$26.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $32.3 million in Q1 2023 to a low of -$103.9 million in Q3 2022.
  • A 5-year average of -$6.8 million and a median of -$3.3 million in 2021 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 355.09% in 2022, then tumbled 3351.33% in 2023.
  • Orthopediatrics' Cash from Investing Activities stood at $3.0 million in 2021, then crashed by 883.37% to -$23.2 million in 2022, then soared by 177.16% to $17.9 million in 2023, then plummeted by 113.46% to -$2.4 million in 2024, then plummeted by 200.95% to -$7.3 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Cash from Investing Activities are -$7.3 million (Q4 2025), -$26.8 million (Q3 2025), and -$3.5 million (Q2 2025).